Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium

Circulation Research

Volumn 86, Issue 8, 2000, Pages 846-853

  Heling, Annette ^a   Zimmermann, René ^b   Kostin, Sawa ^a   Maeno, Yoshi ^a   Hein, Stefan ^b   Devaux, Bruno ^c   Bauer, Erwin ^b   Klövekorn, Wolf Peter ^b   Schlepper, Martin ^a   Schaper, Wolfgang ^a   Schaper, Jutta ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b KERCKHOFF HEART CENTER   (Germany)

^c Max Planck Institute ^*

Author keywords

Cardiomyopathy; Cytoskeleton; Fibrosis; Heart failure; Structure

Indexed keywords

ALPHA TUBULIN; BETA TUBULIN; CELL PROTEIN; DESMIN; FIBRONECTIN; VIMENTIN; VINCULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOSKELETON; FEMALE; HEART DILATATION; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART VENTRICLE COMPLIANCE; HUMAN; HUMAN TISSUE; MALE; MICROTUBULE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMERE;

EID: 0034724943     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.8.846     Document Type: Article

References (47)

1. Braunwald E. Pathophysiology of heart failure. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia, Pa: WB Saunders Co Inc: 1980:453-483.
2. Hein S, Scholz D, Fujitani N, Rennollet H, Brand T, Friedl A, Schaper J. Altered expression of titin and contractile proteins in failing human myocardium. J Mol Cell Cardiol. 1994;26:1291-1306.
3. Schaper J, Froede R, Hein S, Buck A, Hashizume H, Speiser B, Friedl A, Bleese N. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation. 1991;83:504-514.
4. Schaper J, Speiser B, Brand T. The cytoskeleton and extracellular matrix in human hearts with dilated cardiomyopathy. In: Figulla HR, Kandolf R, McManus B, eds. Idiopathic Dilated Cardiomyopathy. Berlin, Germany: Springer-Verlag; 1993:75-80.
5. Grossman W, Jones D, McLaurin MP. Wall stress and patterns of hypertrophy in the human left ventricle, J Clin Invest. 1975;56:56-64.
6. Tsutsui H, Ishihara K, Cooper G. Cytoskeletal role for contractile dysfunction of hypertrophied myocardium. Science. 1993;260:682-687.
7. Tsutsui H, Tagawa H, Kent RL, McCollam PL, Ishihara K, Nagatsu M, Cooper G. Role of microtubules in contractile dysfunction of hypertrophied cardiocytes. Circulation. 1994;90:533-555.
8. Tagawa H, Koide M, Sato H, Zile MR, Carabello BA, Cooper G. Cytoskeletal role in the transition from compensated to decompensated hypertrophy during adult canine left ventricular pressure overloading. Circ Res. 1998;82:751-761.
9. Tagawa H, Koide M, Sato I, Cooper G. Cytoskeletal role in the contractile dysfunction of cardiocytes from hypertrophied and failing right ventricular myocardium. Proc Assoc Am Physicians. 1996;108:218-229.
10. Tagawa H, Rozich JD, Tsutsui H, Narishige T, Kuppuswamy D, Sato H, McDermott PJ, Koide M, Cooper G. Basis for increased microtubules in pressure-hypertrophied cardiocytes. Circulation. 1996;93:1230-1243.
11. Tagawa H, Wang N, Narishige T, Ingber DE, Zile MR, Cooper G. Cytoskeletal mechanics in pressure-overload cardiac hypertrophy. Circ Res. 1997;80:281-289.
12. Sato II, Nagai T, Kuppuswamy D, Narishige T, Koide M, Menick DR, Cooper G. Microtubule stabilization in pressure overload cardiac hypertrophy. J Cell Biol. 1997;139:963-973.
13. Watson PA, Hannan R, Carl LL, Giger KE. Contractile activity and passive strength regulate tubulin mRNA and protein content in cardiac myocytes. Am J Physiol. 1996;271(2pt 1):C684-C689.
14. Wang X, Li F, Campbell SE, Gerdes M. Chronic pressure overload hypertrophy and failure in guinea pigs, II: Cytoskeletal remodeling. J Mol Cell Cardiol 1999;31:319-331.
15. Collins JF, Pawloski-Dahm C, Davies MG, Ball N, Dom GW, Walsh RA. The role of the cytoskeleton in left ventricular pressure overload hypertrophy and failure. J Mol Cell Cardiol. 1996;28:1435-1443.
16. Bailey BA, Dipla K, Li S, Houser SR. Cellular basis of contractile derangements of hypertrophied ventricular myocytes. J Mol Cell Cardiol. 1997;29:1823-1835.
17. de Tombe PP. Altered contractile function in heart failure. Cardiovasc Res. 1998;37:367-380.
18. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162:156-159.
19. Kostin S, Scholz D, Shimada T, Maeno Y, Mollnau H, Hein S, Schaper J. The internal and external protein scaffold of the T-tubular system in cardiomyocytes. Cell Tissue Res. 1998;94:449-460.
20. Stromer MH. The cytoskeleton in skeletal, cardiac and smooth muscle cells. Histol Histopathol. 1998;13:283-291.
21. Kostin S, Heling A, Hein S, Scholz D, Klövekom W-P, Schaper J. The protein composition of the normal and diseased cardiac myocyte. Heart Fail Rev. 1998;2:245-260.
22. Watkins SC, Samuel JL, Marotte F, Bertier-Savalle B, Rappaport L. Microtubules and desmin filaments during onset of heart hypertrophy in the rat: a double immunoelectron microscope study. Circ Res. 1987;60:327-336.
23. Scholz D, Diener W, Schaper J. Altered nucleus/cytoplasm relationship and degenerative structural changes in human dilated cardiomyopathy. Cardioscience. 1994;5:127-138.
24. Capetanaki A, Milner DJ, Weitzer G. Desmin in muscle formation and maintenance: knockouts and consequences. Cell Struct Funct. 1997;22: 103-116.
25. Milner DJ, Weitzer G, Tran D, Bradley A, Capetanaki Y. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J Cell Biol. 1996;134:1255-1270.
26. Thornell LE, Johanson B, Erikson A, Lehto VP, Virtanen I. Intermediate filament and associated proteins in the human heart: an immunofluorescence study of normal and pathological hearts. Eur Heart J. 1984;5(suppl F):231-241.
27. Thomell LE, Price MG. The cytoskeleton in muscle cells in relation to function. Biochem Soc Transact. 1991;19:1116-1120.
28. Thornell LE, Carlsson L, Li Z, Mericskay M, Paulin D. Null mutation in the desmin gene gives rise to a cardiomyopathy. J Mol Cell Cardiol. 1997;29: 2107-2124.
29. Geiger B. Vinculin, an intracellular protein localized at specialized sites where microfilaments bundles terminate at cell membranes. Proc Natl Acad Sci USA. 1980;77:4127-4131.
30. Craig SW, Pardo JV. Gamma actin, spectrin, and intermediate filament proteins colocalize with vinculin at costameres, myofibril-to-sarcolemma attachment sites. Cell Motil. 1983;3:449-462.
31. Pardo JV, Siliciano J, Craig SW. Vinculin is a component of an extensive network of myofibril-sarcolemma attachment regions in cardiac muscle fibers. J Cell Biol. 1983;97:1081-1088.
32. Enomoto Ml, Boettiger D, Menko AS. α5-Integrin is a critical component of adhesion plaques in myogenesis. Dev Biol. 1993;155:180-197.
33. Ortiz-Lopez R, Hua L, Su J, Goytia V, Towbin JA. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation. 1997;95:2434-2440.
34. Arber S, Hunter JJ, Ross J Jr, Hongo M, Sansig G, Borg J, Perriard J-C, Chien KR, Caroni P. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell. 1987; 88:393-403.
35. Badorff C, Lee GH, Lamphear BL, Martone ME, Campbell KP, Rhoads RE, Knowlton KU. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med. 1999;5: 320-326.
36. Towbin JA. The role of cytoskeletal proteins in cardiomyopathies. Curr Opin Cell Biol. 1998;10:131-139.
37. Towbin JA, Bowles KR, Bowles NE. Etiologies of cardiomyopathy and heart failure. Nat Med. 1999;5:266-267.
38. Hynes RO. Fibronectins. Berlin, Germany: Springer; 1989.
39. Schaper J, Hein S, Scholz D, Mollnau H. Multifaceted morphological alterations are present in the failing human heart. J Mol Cell Cardiol. 1995;27: 857-861.
40. Traub P. Intermediate Filaments: A Review. Berlin, Germany: Springer-Verlag; 1985.
41. Zimmermann R, Kastens J, Linz W, Wiemer G, Schölkens BA, Schaper J. Effect of long-term ACE inhibition on myocardial tissue in hypertensive stroke-prone rats. J Mol Cell Cardiol. 1999;31:1447-1456.
42. Weber KT, Brilla CG, Janicki JS. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res. 1993;27:341-348.
43. Wang N, Butler JP, Ingber DE. Mechanotransduction across the cell surface and through the cytoskeleton. Science. 1993;260:1124-1127.
44. Wang N, Ingber DE. Control of cytoskeletal mechanics by extracellular matrix, cell shape, and mechanical tension. Biophys J. 1994;66:2181-2189.
45. Choquet D, Felsenfeld DP, Sheetz MP. Extracellular-matrix rigidity causes strengthening of integrin-cytoskeleton linkages. Cell. 1997;88:39-48.
46. Chien KR. Stress pathways and heart failure. Cell. 1999;98:555-558.
47. Coral-Vazquez R, Cohn RD, Moore SA. Hill JA, Weiss RM, Davisson RL, Straub V, Barresi R, Bansal D, Hrstka RF, Williamson R, Campbell K. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell. 1999; 98:465-474.